The results from interruption assays using sh-ANGPT-2 revealed that suppressing ANGPT-2 expression led to partly reversing the oeERβ-increased ANGPT-2 expression in RCC A498 cells. The gene discussed is ANGPT2; the disease is renal cell carcinoma.